Eurofins Scient (OTCMKTS:ERFSF) Sees Significant Decrease in Short Interest

Eurofins Scient (OTCMKTS:ERFSF) was the recipient of a large decline in short interest in the month of January. As of January 15th, there was short interest totaling 86,941 shares, a decline of 66.8% from the December 31st total of 261,757 shares. Based on an average trading volume of 27,237 shares, the short-interest ratio is presently 3.2 days. Currently, 0.0% of the shares of the company are short sold. Currently, 0.0% of the shares of the company are short sold. Based on an average trading volume of 27,237 shares, the short-interest ratio is presently 3.2 days.

Eurofins Scient Trading Up 1.1%

Shares of ERFSF stock traded up $0.87 on Friday, hitting $81.92. The company had a trading volume of 1,369 shares, compared to its average volume of 9,199. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 1.26. The company has a 50-day moving average price of $75.25 and a 200-day moving average price of $74.38. Eurofins Scient has a twelve month low of $48.55 and a twelve month high of $86.20.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Eurofins Scient in a report on Wednesday, October 29th. Citigroup restated a “neutral” rating on shares of Eurofins Scient in a report on Wednesday, October 22nd. Finally, BNP Paribas Exane raised Eurofins Scient to an “outperform” rating in a research note on Monday, January 5th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Eurofins Scient has a consensus rating of “Moderate Buy”.

About Eurofins Scient

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.